Related Experiment Video
Updated: Jun 11, 2026

Applying Stereotactic Injection Technique to Study Genetic Effects on Animal Behaviors
Published on: May 10, 2015
miR-708-5p is elevated in bipolar patients and can induce mood disorder-associated behavior in mice
Carlotta Gilardi1, Helena C Martins1, Brunno Rocha Levone1
1Laboratory of Systems Neuroscience, Institute for Neuroscience, Department of Health Science and Technology, ETH Zurich, 8057, Zurich, Switzerland.
Abstract:
Mood disorders (MDs) are caused by an interplay of genetic and environmental (GxE) risk factors. However, molecular pathways engaged by GxE risk factors are poorly understood. Using small-RNA sequencing in peripheral blood mononuclear cells (PBMCs), we show that the bipolar disorder (BD)-associated microRNA miR-708-5p is upregulated in healthy human subjects with a high genetic or environmental predisposition for MDs. miR-708-5p is further upregulated in the hippocampus of rats which underwent juvenile social isolation, a model of early life stress. Hippocampal overexpression of miR-708-5p in adult male mice is sufficient to elicit MD-associated behavioral endophenotypes. We further show that miR-708-5p directly targets Neuronatin (Nnat), an endoplasmic reticulum protein. Restoring Nnat expression in the hippocampus of miR-708-5p-overexpressing mice rescues miR-708-5p-dependent behavioral phenotypes. Finally, miR-708-5p is upregulated in PBMCs from patients diagnosed with MD. Peripheral miR-708-5p expression allows to differentiate male BD patients from patients suffering from major depressive disorder (MDD). In summary, we describe a potential functional role for the miR-708-5p/Nnat pathway in MD etiology and identify miR-708-5p as a potential biomarker for the differential diagnosis of MDs.
Insights
MicroRNA miR-708-5p is elevated in individuals predisposed to mood disorders (MDs) and in patients diagnosed with MDs. This microRNA targets Neuronatin (Nnat), suggesting a role in MD etiology and diagnosis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mood disorders result from complex genetic and environmental interactions.
- Molecular mechanisms underlying mood disorder risk are not fully understood.
Purpose of the Study:
- Investigate the role of microRNA miR-708-5p in mood disorder (MD) etiology.
- Identify miR-708-5p as a potential diagnostic biomarker for MDs.
Main Methods:
- Small-RNA sequencing in peripheral blood mononuclear cells (PBMCs).
- In vivo studies using rat and mouse models of early life stress and mood disorder endophenotypes.
- Direct targeting and rescue experiments involving miR-708-5p and Neuronatin (Nnat).
Main Results:
- miR-708-5p is upregulated in individuals with high genetic/environmental risk for MDs and in MD patients.
- Hippocampal miR-708-5p overexpression induces MD-associated behaviors in mice.
- miR-708-5p directly targets Nnat; Nnat restoration rescues behavioral deficits.
- Peripheral miR-708-5p differentiates bipolar disorder (BD) from major depressive disorder (MDD) patients.
Conclusions:
- The miR-708-5p/Nnat pathway is implicated in mood disorder pathogenesis.
- Peripheral miR-708-5p shows potential as a biomarker for differential diagnosis of mood disorders.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Bipolar Disorder

